Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
72.35 CHF | +0.35% | -2.55% | +42.44% |
26/04 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
25/04 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.44% | 1.27B | |
+26.47% | 664B | |
+25.70% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.53% | 234B | |
+4.71% | 199B | |
-10.22% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals N : to Receive $6 Million Milestone Payment from Acacia on First US Sale of Byfavo